Building a career in psychedelics isn't as crazy as it sounded five years ago.
19 Jun 2026 · 1 min

0:35
In this segment, the speaker explains that a Schedule I classification denotes no recognized medical benefit and a high potential for addiction, citing methamphetamine, cocaine, and crack as examples. The speaker argues that psychedelics were deliberately placed on Schedule I sixty years ago to restrict access. The discussion then shifts to recent federal developments: the Department of Health and Human Services and the DEA have begun to acknowledge the medical benefits of cannabis, and they are now poised to recognize the medical benefits of psilocybin mushrooms. This policy evolution underpins the growing legitimacy of careers in the psychedelic sector.











